Granisetron Hydrochloride

CAS 107007-99-8 13 FDA-DMF suppliersSmall Molecule

Overview

Granisetron Hydrochloride is a serotonin 5-HT3 receptor antagonist used primarily as an antiemetic to treat nausea and vomiting following chemotherapy. It works by blocking serotonin from binding to 5-HT3 receptors located on vagal nerve terminals and in the chemoreceptor trigger zone.

API suppliers (22)

Suppliers of Granisetron Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • Natco PharmaIndia1 active DMF
  • WAVELENGTH ENTERPRISES LTDIsrael1 active DMF
  • INKE SASpain1 active DMF
  • WAVELENGTH ENTERPRISES LTDIsrael1 active DMF
  • Wockhardt LimitedIndia1 active DMF
  • Natco PharmaIndia1 active DMF
  • ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
  • SCINOPHARM TAIWAN LTD1 active DMF
  • INKE SASpain1 active DMF
  • Natco PharmaIndia1 active DMF
  • Wockhardt LimitedIndia1 active DMF
  • ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
  • SCINOPHARM TAIWAN LTD1 active DMF
  • INKE SASpain1 active DMF
  • Natco PharmaIndia1 active DMF
  • Wockhardt LimitedIndia1 active DMF
  • ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
  • SCINOPHARM TAIWAN LTD1 active DMF
  • F2 CHEMICALS LTD
  • Sun Pharmaceutical Industries LimitedIndia
  • MYLAN LABORATORIES LTD
  • HAMARI CHEMICALS LTD

Therapeutic areas

OncologyGastroenterology

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.